Showing results (101-110 of 270) with videos related to
Sort By:
Pageof 27
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 21, 2020
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancerRicardo G Pastorello, Alison Laws, Samantha Grossmith, et al.Breast Cancer Research and Treatment|May 20, 2014
Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancersNadine Tung, Elizabeth Gaughan, Michele R Hacker, et al.Oncotarget|March 7, 2018
Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancerWei Yang, Gary N Schwartz, Jonathan D Marotti, et al.NPJ Breast Cancer|January 26, 2016
Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009)Nancy Krieger, Laurel A Habel, Pamela D Waterman, et al.Breast Cancer Research and Treatment|August 17, 2010
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort studyShaheenah Dawood, Rong Hu, Michelle D Homes, et al.Annals of Surgical Oncology|June 11, 2015
Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control StudyLaura C Collins, Ninah Achacoso, Reina Haque, et al.Breast Cancer Research and Treatment|April 30, 2013
Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situLaura C Collins, Ninah Achacoso, Reina Haque, et al.Cell|November 30, 2007
A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasionMichael Overholtzer, Arnaud A Mailleux, Ghassan Mouneimne, et al.Journal of the American Society of Cytopathology|April 27, 2024
Does ROSE matter? Evaluation of final diagnostic, PD-L1 immunohistochemistry, and molecular testing yields of CT-guided lung biopsies performed before and after the onset of the COVID-19 pandemicEmma B Jennings, Robert B Percarpio, Laura J Tafe, et al.Oncogene|April 20, 2021
High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancerNicole A Traphagen, Sarah R Hosford, Amanda Jiang, et al.Pageof 27